SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

Quidel plans initial release to professional and point-of-care segments with a goal of expansion to serve telemedicine and home markets Sofia Q is the latest product in Quidel’s best-selling Sofia ...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...

WASHINGTON (AP) Â Speed and accuracy are key features when screening for coronavirus. Quidel Corp. is one of a handful of U.S. companies authorized to sell a rapid test for COVID-19, yielding results ...

SAN FRANCISCO - The Pac-12 Conference announced today that it has entered into an agreement with diagnostic test leader Quidel Corporation to implement up to daily testing SAN FRANCISCO - The Pac-12 ...

As first reported by The San Jose Mercury News, the UA has been using Quidel Corporation’s rapid-response antigen tests since late May. The person in charge of the school’s testing program — Dr. David ...

The FDA’s emergency use authorization (EUA) program for rapid antigen tests for the COVID-19 pandemic is coming to an end, but few rapid antigen test makers have laid out clear plans regarding the ...